Vitaminality Ltd NI649589 true 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is retail of vitamins Digita Accounts Production Advanced 6.30.9574.0 true Pillpacplus Ltd Mr Mark William Bosket Mr Kenneth Hamill NI649589 2023-04-01 2024-03-31 NI649589 2024-03-31 NI649589 bus:OrdinaryShareClass1 2024-03-31 NI649589 core:ShareCapital 2024-03-31 NI649589 core:CurrentFinancialInstruments 2024-03-31 NI649589 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 NI649589 bus:FRS102 2023-04-01 2024-03-31 NI649589 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 NI649589 bus:FullAccounts 2023-04-01 2024-03-31 NI649589 bus:RegisteredOffice 2023-04-01 2024-03-31 NI649589 bus:Director1 2023-04-01 2024-03-31 NI649589 bus:Director2 2023-04-01 2024-03-31 NI649589 bus:Director3 2023-04-01 2024-03-31 NI649589 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 NI649589 bus:EntityHasNeverTraded 2023-04-01 2024-03-31 NI649589 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 NI649589 countries:NorthernIreland 2023-04-01 2024-03-31 NI649589 2023-03-31 NI649589 bus:OrdinaryShareClass1 2023-03-31 NI649589 core:ShareCapital 2023-03-31 NI649589 core:CurrentFinancialInstruments 2023-03-31 NI649589 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: NI649589

Vitaminality Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2024

 

Vitaminality Ltd

Profit and Loss Account for the Year Ended 31 March 2024

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

Vitaminality Ltd

(Registration number: NI649589)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Current assets

 

Debtors

3

100

100

Capital and reserves

 

Called up share capital

4

100

100

Shareholders' funds

 

100

100

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 29 November 2024 and signed on its behalf by:
 

.........................................
Pillpacplus Ltd
Director

 

Vitaminality Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in Northern Ireland.

The address of its registered office is:
Unit 9
20 Antrim Road
Ballymena
Co. Antrim
BT42 2BJ
N. Ireland

These financial statements were authorised for issue by the Board on 29 November 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Trade debtors

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the income statement in operating expenses.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Debtors

Current

2024
£

2023
£

Other debtors

100

100

 

100

100

 

Vitaminality Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

4

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary Shares of £1 each

100

100

100

100